SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.
Got a hunch that XBI/IBB are going to bust out, after holding the breakout from a 3+ year range Best-looking ones in XBI are KURA, NTLA, DNLI, TPTX, FATE, KOD, TWST.
Recently, EGRX had a strong finish to the month of July 2021; the first time it closed a month above the 200 sma this decade. Recently reported earnings and delivered a bounce above the 50 sma.